Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig08901 |
lipase maturation factor 2 |
245 |
20 |
2.09E-28 |
70.25% |
2 |
C:membrane; C:endoplasmic reticulum |
|
|
contig08902 |
---NA--- |
242 |
0 |
|
|
0 |
|
|
|
contig08903 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig08904 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig08905 |
unnamed protein product [Tetraodon nigroviridis] |
260 |
1 |
1.88E-08 |
75.00% |
0 |
|
|
|
contig08906 |
zinc binding alcohol domain containing 2 |
256 |
20 |
3.89E-38 |
87.10% |
4 |
P:protein targeting; P:metabolic process; F:alcohol dehydrogenase activity, zinc-dependent; F:zinc ion binding |
|
|
contig08907 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig08908 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig08909 |
mediator complex subunit 28 |
262 |
20 |
1.86E-24 |
78.70% |
4 |
F:protein binding; P:transcription antitermination; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
contig08910 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig08911 |
---NA--- |
291 |
0 |
|
|
0 |
|
|
|
contig08912 |
---NA--- |
218 |
0 |
|
|
0 |
|
|
|
contig08913 |
la ribonucleoprotein domain member 7 |
251 |
20 |
1.40E-16 |
69.05% |
1 |
F:binding |
|
|
contig08914 |
---NA--- |
188 |
0 |
|
|
0 |
|
|
|
contig08915 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig08916 |
nidogen 2 |
243 |
20 |
1.31E-38 |
68.70% |
4 |
P:cell-matrix adhesion; C:extracellular space; F:collagen binding; C:basement membrane |
|
|
contig08917 |
membrane-associated dhhc14 zinc finger protein isoform 1 |
249 |
20 |
6.92E-24 |
77.50% |
2 |
F:metal ion binding; F:transferase activity |
|
|
contig08918 |
rad17 homolog |
231 |
20 |
5.59E-21 |
81.55% |
9 |
F:nucleoside-triphosphatase activity; P:DNA repair; P:negative regulation of DNA replication; P:regulation of phosphorylation; F:ATP binding; F:protein binding; P:multicellular organismal development; P:mitotic cell cycle checkpoint; C:nucleus |
EC:3.6.1.15 |
|
contig08919 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig08920 |
---NA--- |
218 |
0 |
|
|
0 |
|
|
|
contig08921 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig08922 |
---NA--- |
242 |
0 |
|
|
0 |
|
|
|
contig08923 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig08924 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig08925 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig08926 |
---NA--- |
137 |
0 |
|
|
0 |
|
|
|
contig08927 |
la ribonucleoprotein domain member 6 |
1043 |
20 |
2.47E-24 |
83.55% |
5 |
F:RNA binding; C:cytoplasm; C:ribonucleoprotein complex; P:RNA processing; C:nucleus |
|
|
contig08928 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig08929 |
---NA--- |
272 |
0 |
|
|
0 |
|
|
|
contig08930 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig08931 |
transmembrane and coiled-coil domain-containing protein c6orf129 homolog |
251 |
1 |
1.27E-09 |
92.00% |
0 |
|
|
|
contig08932 |
inversin |
248 |
20 |
5.97E-14 |
96.00% |
9 |
C:cytoplasm; P:Wnt receptor signaling pathway; F:DNA binding; P:multicellular organismal development; C:spindle; C:membrane; C:nucleus; F:calmodulin binding; C:microtubule |
|
|
contig08933 |
jumonji domain containing 8 |
242 |
20 |
1.07E-17 |
86.10% |
0 |
|
|
|
contig08934 |
---NA--- |
289 |
0 |
|
|
0 |
|
|
|
contig08935 |
---NA--- |
265 |
0 |
|
|
0 |
|
|
|
contig08936 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
contig08937 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
contig08938 |
slain motif member 2 |
244 |
20 |
1.80E-25 |
79.80% |
0 |
|
|
|
contig08939 |
protein kinase c and casein kinase substrate in neurons 3 |
252 |
20 |
4.49E-18 |
70.35% |
9 |
C:integral to membrane; F:cytoskeletal protein binding; P:endocytosis; F:enzyme binding; P:negative regulation of endocytosis; C:cytoplasm; F:kinase activity; P:G-protein coupled receptor protein signaling pathway; C:plasma membrane |
|
|
contig08940 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig08941 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig08942 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig08943 |
member ras oncogene family |
250 |
20 |
9.01E-32 |
97.45% |
16 |
C:photoreceptor outer segment; P:melanosome transport; P:natural killer cell degranulation; P:protein targeting; C:melanosome; F:GTP binding; C:Golgi apparatus; P:melanocyte differentiation; C:dendrite; P:small GTPase mediated signal transduction; P:blood coagulation; C:secretory granule membrane; F:GTPase activity; F:myosin V binding; P:cytotoxic T cell degranulation; C:apical plasma membrane |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig08944 |
chemokine (c-c motif) receptor 6a |
700 |
1 |
5.12E-15 |
78.00% |
2 |
F:receptor activity; C:C |
|
|
contig08945 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig08946 |
nucleolar protein family 6 |
252 |
1 |
8.22E-04 |
83.00% |
0 |
|
|
|
contig08947 |
zinc finger protein 425 |
247 |
20 |
3.12E-16 |
63.05% |
1 |
F:binding |
|
|
contig08948 |
---NA--- |
286 |
0 |
|
|
0 |
|
|
|
contig08949 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig08950 |
---NA--- |
265 |
0 |
|
|
0 |
|
|
|
contig08951 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 |
252 |
20 |
3.32E-29 |
81.00% |
12 |
P:myelination; P:startle response; P:glial cell migration; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:ATP binding; P:axonal fasciculation; P:myelination of posterior lateral line nerve axons; P:myelination of anterior lateral line nerve axons; F:transmembrane receptor protein tyrosine kinase activity; P:Schwann cell development; C:membrane; P:protein amino acid phosphorylation |
EC:2.7.10.1 |
|
contig08952 |
myosin va |
250 |
20 |
8.77E-11 |
76.85% |
8 |
C:cytoplasm; F:microfilament motor activity; C:growth cone; C:neuron projection; F:protein binding; C:ruffle; F:nucleotide binding; P:actin filament-based movement |
|
|
contig08953 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig08954 |
---NA--- |
587 |
0 |
|
|
0 |
|
|
|
contig08955 |
mediator complex subunit 16 |
255 |
20 |
1.94E-29 |
92.05% |
4 |
F:receptor activity; ; P:transcription from RNA polymerase II promoter; P:regulation of transcription, DNA-dependent |
|
|
contig08956 |
haloacid dehalogenase-like hydrolase domain containing 1a |
242 |
20 |
8.52E-30 |
84.25% |
2 |
F:catalytic activity; P:metabolic process |
|
|
contig08957 |
---NA--- |
241 |
0 |
|
|
0 |
|
|
|
contig08958 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
contig08959 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig08960 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig08961 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig08962 |
b630005n14rik protein |
248 |
20 |
6.28E-25 |
89.30% |
2 |
P:P; C:C |
|
|
contig08963 |
elmo domain containing 2 |
248 |
20 |
1.60E-20 |
71.10% |
1 |
P:phagocytosis |
|
|
contig08964 |
wings apart-like homolog |
247 |
20 |
6.28E-25 |
86.15% |
1 |
P:response to toxin |
|
|
contig08965 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig08966 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig08967 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig08968 |
novel protein (zgc:13078) |
252 |
6 |
1.71E-09 |
77.00% |
2 |
F:F; P:P |
|
|
contig08969 |
dipeptidyl peptidase iii |
249 |
20 |
1.94E-26 |
89.20% |
6 |
C:cytoplasm; F:metallopeptidase activity; P:proteolysis; F:zinc ion binding; F:aminopeptidase activity; F:dipeptidyl-peptidase III activity |
EC:3.4.11.0; EC:3.4.14.4 |
|
contig08970 |
swi snf matrix actin dependent regulator of subfamily member 5 |
272 |
20 |
5.52E-37 |
95.85% |
17 |
P:regulation of transcription from RNA polymerase II promoter; F:histone binding; P:transcription initiation; P:ATP-dependent chromatin remodeling; F:DNA binding; F:ATP binding; C:RSF complex; P:nucleosome positioning; F:nucleosome binding; P:embryonic development; F:ATPase activity; F:transcription activator activity; F:helicase activity; P:nucleosome assembly; C:condensed chromosome; P:retina development in camera-type eye; F:RNA polymerase II transcription factor activity |
|
|
contig08971 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig08972 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig08973 |
---NA--- |
322 |
0 |
|
|
0 |
|
|
|
contig08974 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
contig08975 |
---NA--- |
257 |
0 |
|
|
0 |
|
|
|
contig08976 |
zinc finger protein 292 |
251 |
16 |
4.35E-10 |
62.63% |
3 |
F:nucleic acid binding; F:F; P:P |
|
|
contig08977 |
unnamed protein product [Tetraodon nigroviridis] |
251 |
1 |
6.28E-09 |
98.00% |
0 |
|
|
|
contig08978 |
cyclic amp 19 kd |
269 |
20 |
5.19E-35 |
90.95% |
7 |
P:positive regulation of Ras protein signal transduction; P:positive regulation of glucose import; F:potassium channel regulator activity; F:receptor binding; P:positive regulation of gluconeogenesis; P:dopamine receptor signaling pathway; C:cytoplasm |
|
|
contig08979 |
myomesin 1 |
258 |
20 |
1.43E-24 |
64.65% |
4 |
F:structural constituent of cytoskeleton; C:cytoskeleton; F:structural constituent of muscle; C:sarcomere |
|
|
contig08980 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig08981 |
carnitine o-octanoyltransferase |
248 |
20 |
2.83E-09 |
77.15% |
4 |
C:peroxisome; F:carnitine O-octanoyltransferase activity; P:long-chain fatty acid transport; P:fatty acid metabolic process |
EC:2.3.1.137 |
|
contig08982 |
unnamed protein product [Tetraodon nigroviridis] |
267 |
1 |
6.19E-04 |
69.00% |
0 |
|
|
|
contig08983 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig08984 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig08985 |
srrt protein |
243 |
20 |
4.52E-15 |
67.10% |
1 |
F:protein binding |
|
|
contig08986 |
apaf1 interacting protein |
270 |
19 |
3.86E-06 |
95.58% |
9 |
P:negative regulation of apoptosis; F:identical protein binding; P:apoptosis; C:cytoplasm; F:zinc ion binding; F:F; P:zinc ion transport; C:C; F:metal ion binding |
|
|
contig08987 |
unnamed protein product [Tetraodon nigroviridis] |
249 |
1 |
3.21E-21 |
76.00% |
0 |
|
|
|
contig08988 |
novel protein membrane associated guanylate ww and pdz domain containing 1 |
264 |
4 |
8.07E-20 |
76.25% |
0 |
|
|
|
contig08989 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig08990 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig08991 |
orm1-like 1 |
258 |
20 |
6.43E-25 |
97.40% |
3 |
C:endoplasmic reticulum membrane; C:membrane attack complex; P:protein targeting |
|
|
contig08992 |
myst histone acetyltransferase (monocytic leukemia) 3 |
259 |
20 |
3.18E-32 |
81.85% |
20 |
P:embryonic pattern specification; P:positive regulation of transcription; F:zinc ion binding; F:histone acetyltransferase activity; P:regulation of transcription, DNA-dependent; P:embryonic hemopoiesis; P:cartilage condensation; P:neural crest cell fate specification; C:nucleosome; P:embryonic skeletal system development; P:somatic stem cell maintenance; F:DNA binding; P:myeloid cell differentiation; P:zinc ion transport; P:negative regulation of transcription; P:embryonic body morphogenesis; P:nucleosome assembly; F:transcription factor binding; C:nucleus; P:histone acetylation |
EC:2.3.1.48 |
|
contig08993 |
wd repeat domain 75 |
677 |
20 |
1.22E-10 |
63.80% |
1 |
C:nucleus |
|
|
contig08994 |
kh-type splicing regulatory protein |
257 |
20 |
1.64E-28 |
95.50% |
12 |
F:mRNA 3'-UTR binding; P:regulation of transcription, DNA-dependent; F:DNA binding; F:ATP binding; F:protein binding; F:aminoacyl-tRNA ligase activity; P:nuclear mRNA splicing, via spliceosome; P:mRNA export from nucleus; P:tRNA aminoacylation for protein translation; ; C:cytoplasm; C:nucleus |
|
|
contig08995 |
---NA--- |
302 |
0 |
|
|
0 |
|
|
|
contig08996 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig08997 |
lon peptidase n-terminal domain and ring finger 1 |
248 |
20 |
7.67E-23 |
83.40% |
4 |
F:ATP-dependent peptidase activity; F:zinc ion binding; F:protein binding; P:ATP-dependent proteolysis |
|
|
contig08998 |
---NA--- |
242 |
0 |
|
|
0 |
|
|
|
contig08999 |
acidic (leucine-rich) nuclear phosphoprotein 32 member a |
263 |
20 |
3.75E-33 |
96.65% |
6 |
; F:protein binding; P:nucleocytoplasmic transport; C:nuclear matrix; C:endoplasmic reticulum; C:perinuclear region of cytoplasm |
|
|
contig09000 |
gc-rich promoter binding protein 1-like 1 |
240 |
20 |
1.56E-23 |
72.95% |
5 |
P:transcription; F:zinc ion binding; C:nucleus; F:DNA binding; C:intracellular |
|
|
100 Rows returned.